Appian Aktie
Appian Aktie
Was spricht für und gegen Appian in den nächsten Jahren?
Pro
Kontra
Rendite von Appian im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Appian | -1,74 % | 18,93 % | 14,63 % | -8,34 % | -24,22 % | -49,11 % | -76,59 % |
| Asure Software | -0,69 % | 11,45 % | 5,80 % | -13,10 % | -7,59 % | -40,16 % | -7,59 % |
| Mitek Systems Inc. | 0,07 % | 5,87 % | -16,00 % | 86,52 % | 65,36 % | 59,48 % | -20,69 % |
| Netsol Technologies | -2,66 % | 0,00 % | -6,47 % | 6,21 % | 46,88 % | 84,31 % | 2,17 % |
Kommentare
News
Stock Market Today, July 21: UiPath Falls 1% Despite Tech Stock Rebound
UiPath (NYSE:PATH), an artificial intelligence (AI) robotic and automation software provider, closed at $12.04, down 0.99%. Recent investment reports that put the spotlight on UiPath's customer
Stock Market Today, July 17: UiPath Gains on Retail AI Partnership
UiPath (NYSE:PATH), an enterprise automation and robotic software provider, closed at $12.15, up 1.00%. The gains follow a recent retail artificial intelligence (AI) partnership, while broader
What Does Appian CEO's Sale of 50,000 Shares for $1.2 Million Mean for Investors?
Matthew W. Calkins, CEO and founder of Appian (NASDAQ:APPN), reported an open-market sale of 50,000 shares for a total of approximately $1.21 million on June 8, 2026, according to a SEC Form 4



